Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study

Whether the reported high risk of age-related diseases in HIV-infected people is caused by biological ageing or HIV-associated risk factors such as chronic immune activation and low-grade inflammation is unknown. We assessed time trends in age-standardised and relative risks of nine serious age-rela...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The lancet HIV Jg. 2; H. 7; S. e288 - e298
Hauptverfasser: Rasmussen, Line D, May, Margaret T, Kronborg, Gitte, Larsen, Carsten S, Pedersen, Court, Gerstoft, Jan, Obel, Niels
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Netherlands 01.07.2015
Schlagworte:
ISSN:2352-3018
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Whether the reported high risk of age-related diseases in HIV-infected people is caused by biological ageing or HIV-associated risk factors such as chronic immune activation and low-grade inflammation is unknown. We assessed time trends in age-standardised and relative risks of nine serious age-related diseases in a nationwide cohort study of HIV-infected individuals and population controls. We identified all HIV-infected individuals in the Danish HIV Cohort Study who had received HIV care in Denmark between Jan 1, 1995, and June 1, 2014. Population controls were identified from the Danish Civil Registration System and individually matched in a ratio of nine to one to the HIV-infected individuals for year of birth, sex, and date of study inclusion. Individuals were included in the study if they had a Danish personal identification number, were aged 16 years or older, and were living in Denmark at the time of study inclusion. Data for study outcomes were obtained from the Danish National Hospital Registry and the Danish National Registry of Causes of Death and were cardiovascular diseases (myocardial infarction and stroke), cancers (virus associated, smoking related, and other), severe neurocognitive disease, chronic kidney disease, chronic liver disease, and osteoporotic fractures. We calculated excess and age-standardised incidence rates and adjusted incidence rate ratios of outcomes for time after HIV diagnosis, highly active antiretroviral therapy (ART) initiation, and calendar time. The regression analyses were adjusted for age, sex, calendar time, and origin. We identified 5897 HIV-infected individuals and 53,073 population controls; median age was 36·8 years (IQR 30·6-44·4), and 76% were men in both cohorts. Dependent on disease, the HIV cohort had 55,050-57,631 person-years of follow-up and the population controls had 638,204-659,237 person-years of follow-up. Compared with the population controls, people with HIV had high excess and relative risk of all age-related diseases except other cancers. Overall, the age-standardised and relative risks of cardiovascular diseases, cancers, and severe neurocognitive disease did not increase substantially with time after HIV diagnosis or ART initiation. Except for chronic kidney diseases, the age-standardised and relative risks of age-related diseases did not increase with calendar time. Severe age-related diseases are highly prevalent in people with HIV, and continued attention and strategies for risk reduction are needed. The findings from our study do not suggest that accelerated ageing is a major problem in the HIV-infected population. Preben og Anna Simonsens Fond, Novo Nordisk Foundation, Danish AIDS Foundation, Augustinus Foundation, and Odense University Hospitals Frie Fonds Midler.
AbstractList Whether the reported high risk of age-related diseases in HIV-infected people is caused by biological ageing or HIV-associated risk factors such as chronic immune activation and low-grade inflammation is unknown. We assessed time trends in age-standardised and relative risks of nine serious age-related diseases in a nationwide cohort study of HIV-infected individuals and population controls. We identified all HIV-infected individuals in the Danish HIV Cohort Study who had received HIV care in Denmark between Jan 1, 1995, and June 1, 2014. Population controls were identified from the Danish Civil Registration System and individually matched in a ratio of nine to one to the HIV-infected individuals for year of birth, sex, and date of study inclusion. Individuals were included in the study if they had a Danish personal identification number, were aged 16 years or older, and were living in Denmark at the time of study inclusion. Data for study outcomes were obtained from the Danish National Hospital Registry and the Danish National Registry of Causes of Death and were cardiovascular diseases (myocardial infarction and stroke), cancers (virus associated, smoking related, and other), severe neurocognitive disease, chronic kidney disease, chronic liver disease, and osteoporotic fractures. We calculated excess and age-standardised incidence rates and adjusted incidence rate ratios of outcomes for time after HIV diagnosis, highly active antiretroviral therapy (ART) initiation, and calendar time. The regression analyses were adjusted for age, sex, calendar time, and origin. We identified 5897 HIV-infected individuals and 53,073 population controls; median age was 36·8 years (IQR 30·6-44·4), and 76% were men in both cohorts. Dependent on disease, the HIV cohort had 55,050-57,631 person-years of follow-up and the population controls had 638,204-659,237 person-years of follow-up. Compared with the population controls, people with HIV had high excess and relative risk of all age-related diseases except other cancers. Overall, the age-standardised and relative risks of cardiovascular diseases, cancers, and severe neurocognitive disease did not increase substantially with time after HIV diagnosis or ART initiation. Except for chronic kidney diseases, the age-standardised and relative risks of age-related diseases did not increase with calendar time. Severe age-related diseases are highly prevalent in people with HIV, and continued attention and strategies for risk reduction are needed. The findings from our study do not suggest that accelerated ageing is a major problem in the HIV-infected population. Preben og Anna Simonsens Fond, Novo Nordisk Foundation, Danish AIDS Foundation, Augustinus Foundation, and Odense University Hospitals Frie Fonds Midler.
BACKGROUNDWhether the reported high risk of age-related diseases in HIV-infected people is caused by biological ageing or HIV-associated risk factors such as chronic immune activation and low-grade inflammation is unknown. We assessed time trends in age-standardised and relative risks of nine serious age-related diseases in a nationwide cohort study of HIV-infected individuals and population controls.METHODSWe identified all HIV-infected individuals in the Danish HIV Cohort Study who had received HIV care in Denmark between Jan 1, 1995, and June 1, 2014. Population controls were identified from the Danish Civil Registration System and individually matched in a ratio of nine to one to the HIV-infected individuals for year of birth, sex, and date of study inclusion. Individuals were included in the study if they had a Danish personal identification number, were aged 16 years or older, and were living in Denmark at the time of study inclusion. Data for study outcomes were obtained from the Danish National Hospital Registry and the Danish National Registry of Causes of Death and were cardiovascular diseases (myocardial infarction and stroke), cancers (virus associated, smoking related, and other), severe neurocognitive disease, chronic kidney disease, chronic liver disease, and osteoporotic fractures. We calculated excess and age-standardised incidence rates and adjusted incidence rate ratios of outcomes for time after HIV diagnosis, highly active antiretroviral therapy (ART) initiation, and calendar time. The regression analyses were adjusted for age, sex, calendar time, and origin.FINDINGSWe identified 5897 HIV-infected individuals and 53,073 population controls; median age was 36·8 years (IQR 30·6-44·4), and 76% were men in both cohorts. Dependent on disease, the HIV cohort had 55,050-57,631 person-years of follow-up and the population controls had 638,204-659,237 person-years of follow-up. Compared with the population controls, people with HIV had high excess and relative risk of all age-related diseases except other cancers. Overall, the age-standardised and relative risks of cardiovascular diseases, cancers, and severe neurocognitive disease did not increase substantially with time after HIV diagnosis or ART initiation. Except for chronic kidney diseases, the age-standardised and relative risks of age-related diseases did not increase with calendar time.INTERPRETATIONSSevere age-related diseases are highly prevalent in people with HIV, and continued attention and strategies for risk reduction are needed. The findings from our study do not suggest that accelerated ageing is a major problem in the HIV-infected population.FUNDINGPreben og Anna Simonsens Fond, Novo Nordisk Foundation, Danish AIDS Foundation, Augustinus Foundation, and Odense University Hospitals Frie Fonds Midler.
Author Rasmussen, Line D
Larsen, Carsten S
May, Margaret T
Kronborg, Gitte
Pedersen, Court
Gerstoft, Jan
Obel, Niels
Author_xml – sequence: 1
  givenname: Line D
  surname: Rasmussen
  fullname: Rasmussen, Line D
  email: linedahlerup@hotmail.com
  organization: Department of Infectious Diseases, Odense University Hospital, Odense, Denmark. Electronic address: linedahlerup@hotmail.com
– sequence: 2
  givenname: Margaret T
  surname: May
  fullname: May, Margaret T
  organization: School of Social and Community Medicine, University of Bristol, Bristol, UK
– sequence: 3
  givenname: Gitte
  surname: Kronborg
  fullname: Kronborg, Gitte
  organization: Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark
– sequence: 4
  givenname: Carsten S
  surname: Larsen
  fullname: Larsen, Carsten S
  organization: Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
– sequence: 5
  givenname: Court
  surname: Pedersen
  fullname: Pedersen, Court
  organization: Department of Infectious Diseases, Odense University Hospital, Odense, Denmark
– sequence: 6
  givenname: Jan
  surname: Gerstoft
  fullname: Gerstoft, Jan
  organization: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
– sequence: 7
  givenname: Niels
  surname: Obel
  fullname: Obel, Niels
  organization: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26423253$$D View this record in MEDLINE/PubMed
BookMark eNo9kMlOxDAMhiMEYhnmEUA-wqHQLE1TbmhYJSQOLNdR2jgQ6DRDks5o3oTHpQyLZcn270-_ZO-Rzc53SMgBzU9oTuXpA-MFy3hO1REtjvM8L8tMbpDdf3mHjGN8Gxa0EKoQbJvsMCkYZwXfJZ-PboaQAnYmgvUBgovv4C1EXGBA0C-YBWx1QgPGRdQRI7huSOMWzvS6jbB06RV0Z9aN7xPc3D4PgMUmOf-NwgV2Mx3ez0BDp7_FpTMIcz_v2_WY1YOvgca_-pAgpt6s9smWHcxx_FtH5Onq8nFyk93dX99Ozu-yphAiZTXKprKV4lJbi0ZZYYcwtBSVVDVa07DKcEUlosit4rqgNZNlXinBLRfIRuTox3ce_EePMU1nLjbYtrpD38cpLamqKJNVMaCHv2hfz9BM58ENV62mf99kX0k6e6k
CitedBy_id crossref_primary_10_3390_metabo13080948
crossref_primary_10_1097_QAI_0000000000001391
crossref_primary_10_1016_j_ijid_2018_02_009
crossref_primary_10_1093_jac_dkv494
crossref_primary_10_1111_acel_13681
crossref_primary_10_1186_s12981_018_0210_2
crossref_primary_10_1016_j_brainres_2019_146398
crossref_primary_10_1016_j_clml_2023_05_006
crossref_primary_10_1136_bmjopen_2018_025874
crossref_primary_10_1371_journal_pone_0226182
crossref_primary_10_1111_jgs_14902
crossref_primary_10_1097_QAI_0000000000001154
crossref_primary_10_1016_j_glohj_2020_04_001
crossref_primary_10_1097_QAD_0000000000001374
crossref_primary_10_1161_STROKEAHA_123_043410
crossref_primary_10_1016_S2352_3018_15_00082_X
crossref_primary_10_1177_10600280241291738
crossref_primary_10_1097_QAD_0000000000003393
crossref_primary_10_1371_journal_pone_0288895
crossref_primary_10_1371_journal_pone_0251303
crossref_primary_10_1371_journal_pone_0246171
crossref_primary_10_1177_1440783318766162
crossref_primary_10_1093_cid_ciaf392
crossref_primary_10_1093_infdis_jiab433
crossref_primary_10_1093_infdis_jiad179
crossref_primary_10_1002_jia2_26434
crossref_primary_10_1097_QAI_0000000000001824
crossref_primary_10_1007_s11904_020_00494_2
crossref_primary_10_1002_jia2_25986
crossref_primary_10_1093_infdis_jiaa580
crossref_primary_10_1080_16070658_2019_1638609
crossref_primary_10_1177_1358863X18789767
crossref_primary_10_1016_j_ijid_2016_10_004
crossref_primary_10_1016_j_sleep_2019_06_020
crossref_primary_10_1097_QAD_0000000000001384
crossref_primary_10_1097_QAI_0000000000002598
crossref_primary_10_1186_s12877_018_0789_0
crossref_primary_10_1097_QAD_0000000000003681
crossref_primary_10_1080_17501911_2025_2491299
crossref_primary_10_1111_hiv_13077
crossref_primary_10_1080_09540121_2018_1476661
crossref_primary_10_1371_journal_pone_0210253
crossref_primary_10_1089_apc_2018_0190
crossref_primary_10_1186_s12981_023_00546_8
crossref_primary_10_1016_j_canrad_2018_06_007
crossref_primary_10_1016_j_cjca_2019_07_636
crossref_primary_10_1016_S2352_3018_18_30336_9
crossref_primary_10_1016_S2352_3018_23_00027_9
crossref_primary_10_1371_journal_pone_0207005
crossref_primary_10_1016_j_antiviral_2018_12_014
crossref_primary_10_1042_BSR20180597
crossref_primary_10_1161_CIRCULATIONAHA_117_033369
crossref_primary_10_1097_QAD_0000000000001677
crossref_primary_10_1007_s10157_019_01768_9
crossref_primary_10_1097_QAI_0000000000002464
crossref_primary_10_1111_hiv_12778
crossref_primary_10_1016_j_exger_2021_111269
crossref_primary_10_1016_j_rec_2016_10_005
crossref_primary_10_1097_QAD_0000000000004140
crossref_primary_10_1016_j_icheatmasstransfer_2021_105694
crossref_primary_10_1080_10428194_2019_1633631
crossref_primary_10_1097_MD_0000000000004890
crossref_primary_10_1093_cid_ciac662
crossref_primary_10_1093_ofid_ofz464
crossref_primary_10_1111_jgs_14584
crossref_primary_10_1016_S2352_3018_22_00400_3
crossref_primary_10_1093_infdis_jiae644
crossref_primary_10_1097_QAD_0000000000001967
crossref_primary_10_1111_tmi_13790
crossref_primary_10_1002_jbmr_4873
crossref_primary_10_1016_j_bulcan_2018_02_002
crossref_primary_10_1111_jgs_17569
crossref_primary_10_1007_s11904_016_0330_z
crossref_primary_10_1007_s11904_016_0315_y
crossref_primary_10_1089_apc_2022_0183
crossref_primary_10_1111_hiv_12800
crossref_primary_10_1093_cid_ciac939
crossref_primary_10_1097_COH_0000000000000306
crossref_primary_10_1097_COH_0000000000000305
crossref_primary_10_1002_hbm_26409
crossref_primary_10_1097_QAD_0000000000002493
crossref_primary_10_1007_s11481_020_09907_w
crossref_primary_10_1089_aid_2017_0128
crossref_primary_10_1097_TIN_0000000000000205
crossref_primary_10_1007_s11904_023_00648_y
crossref_primary_10_1097_COH_0000000000000595
crossref_primary_10_1128_spectrum_01064_23
crossref_primary_10_4103_jgid_jgid_29_24
crossref_primary_10_1093_infdis_jiab186
crossref_primary_10_14283_jfa_2022_56
crossref_primary_10_1097_QAD_0000000000003632
crossref_primary_10_1016_j_ahj_2019_11_004
crossref_primary_10_1093_cid_ciac925
crossref_primary_10_1002_jia2_25034
crossref_primary_10_1093_cercor_bhab045
crossref_primary_10_1016_j_identj_2020_12_006
crossref_primary_10_1371_journal_pone_0185352
crossref_primary_10_1080_09540121_2025_2534126
crossref_primary_10_1093_ofid_ofx064
crossref_primary_10_1093_ofid_ofw097
crossref_primary_10_1007_s41999_018_0147_y
crossref_primary_10_1093_infdis_jix676
crossref_primary_10_1089_aid_2021_0212
crossref_primary_10_1002_jbmr_4894
crossref_primary_10_1097_QAD_0000000000001901
crossref_primary_10_1089_aid_2022_0186
crossref_primary_10_1016_j_ijantimicag_2017_04_021
crossref_primary_10_1093_jac_dkad341
crossref_primary_10_1590_1982_0194201900069
crossref_primary_10_1007_s13365_018_0706_5
crossref_primary_10_1080_03007995_2019_1645999
crossref_primary_10_3389_fimmu_2021_709994
crossref_primary_10_1186_s13098_019_0502_2
crossref_primary_10_1016_j_ebiom_2021_103548
crossref_primary_10_1016_j_repc_2020_03_007
crossref_primary_10_1093_infdis_jix202
crossref_primary_10_3389_fendo_2018_00705
crossref_primary_10_1016_j_heliyon_2024_e31910
crossref_primary_10_1093_ofid_ofaa584
crossref_primary_10_1111_hiv_12616
crossref_primary_10_1080_09540121_2018_1499855
crossref_primary_10_1007_s15006_017_9047_1
crossref_primary_10_1111_imj_14165
crossref_primary_10_1016_j_cell_2021_05_023
crossref_primary_10_1111_ggi_14717
crossref_primary_10_1186_s12889_018_6325_5
crossref_primary_10_1097_QAD_0000000000001076
crossref_primary_10_1371_journal_pone_0243529
crossref_primary_10_1093_jn_nxy241
crossref_primary_10_1097_QAI_0000000000002269
crossref_primary_10_1080_16089677_2022_2084901
crossref_primary_10_1080_23744235_2016_1212168
crossref_primary_10_1093_cid_ciaa1137
crossref_primary_10_1080_2331205X_2021_1920667
crossref_primary_10_1097_QAD_0000000000003260
crossref_primary_10_1136_bmjopen_2020_047314
crossref_primary_10_1016_j_ijid_2018_10_011
crossref_primary_10_1001_jamanetworkopen_2020_22107
crossref_primary_10_1093_infdis_jiz351
crossref_primary_10_1097_MD_0000000000029850
crossref_primary_10_1136_bmjdrc_2017_000457
crossref_primary_10_3390_cancers13225692
crossref_primary_10_1016_j_ebiom_2016_10_015
crossref_primary_10_1016_j_ijid_2016_11_414
crossref_primary_10_1089_aid_2019_0117
crossref_primary_10_1093_jac_dkz224
crossref_primary_10_1016_j_repce_2020_07_001
crossref_primary_10_1016_j_biopha_2023_114427
crossref_primary_10_1093_infdis_jix205
crossref_primary_10_1016_j_jand_2017_12_007
crossref_primary_10_1111_hiv_12689
crossref_primary_10_1186_s12874_021_01448_x
crossref_primary_10_1016_j_jiac_2021_02_003
crossref_primary_10_1093_ofid_ofw278
crossref_primary_10_1093_ofid_ofy216
crossref_primary_10_1097_QAD_0000000000003662
crossref_primary_10_3390_jcm8081125
crossref_primary_10_1136_bmjopen_2020_041734
crossref_primary_10_1111_hiv_13139
ContentType Journal Article
Copyright Copyright © 2015 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: Copyright © 2015 Elsevier Ltd. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/S2352-3018(15)00077-6
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
EISSN 2352-3018
EndPage e298
ExternalDocumentID 26423253
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Denmark
GeographicLocations_xml – name: Denmark
GrantInformation Preben og Anna Simonsens Fond, Novo Nordisk Foundation, Danish AIDS Foundation, Augustinus Foundation, and Odense University Hospitals Frie Fonds Midler.
GroupedDBID -RU
.1-
.FO
0R~
1P~
4.4
457
53G
AAEDT
AAEDW
AALRI
AAMRU
AAQFI
AAXUO
ABJNI
ACGFS
ADBBV
AENEX
AFRHN
AFTJW
AGCQF
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
CGR
CUY
CVF
EBS
ECM
EFKBS
EIF
EJD
FDB
HZ~
M41
NPM
O9-
OD-
OO.
ROL
Z5R
7X8
ID FETCH-LOGICAL-c544t-be6c9f9836affed8f4ffffd174968befdc29d3816ee40f83a51b26709843f34e2
IEDL.DBID 7X8
ISICitedReferencesCount 173
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000363793000009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
IngestDate Sun Sep 28 00:42:01 EDT 2025
Mon Jul 21 06:03:29 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License Copyright © 2015 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c544t-be6c9f9836affed8f4ffffd174968befdc29d3816ee40f83a51b26709843f34e2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 26423253
PQID 1718912695
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1718912695
pubmed_primary_26423253
PublicationCentury 2000
PublicationDate 2015-07-01
PublicationDateYYYYMMDD 2015-07-01
PublicationDate_xml – month: 07
  year: 2015
  text: 2015-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle The lancet HIV
PublicationTitleAlternate Lancet HIV
PublicationYear 2015
References 26423249 - Lancet HIV. 2015 Jul;2(7):e265-6
References_xml – reference: 26423249 - Lancet HIV. 2015 Jul;2(7):e265-6
SSID ssj0001548542
Score 2.425831
Snippet Whether the reported high risk of age-related diseases in HIV-infected people is caused by biological ageing or HIV-associated risk factors such as chronic...
BACKGROUNDWhether the reported high risk of age-related diseases in HIV-infected people is caused by biological ageing or HIV-associated risk factors such as...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage e288
SubjectTerms Adult
Aging
Anti-HIV Agents - therapeutic use
Cardiovascular Diseases - epidemiology
Cohort Studies
Comorbidity
Denmark - epidemiology
Female
HIV Infections - diagnosis
HIV Infections - epidemiology
HIV Infections - virology
Humans
Incidence
Liver Diseases - epidemiology
Male
Neoplasms - epidemiology
Neurocognitive Disorders - epidemiology
Osteoporotic Fractures - epidemiology
Population Surveillance
Regression Analysis
Renal Insufficiency, Chronic - epidemiology
Risk Factors
Title Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study
URI https://www.ncbi.nlm.nih.gov/pubmed/26423253
https://www.proquest.com/docview/1718912695
Volume 2
WOSCitedRecordID wos000363793000009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwELZoaSUuBUp5lIIGqYdysNg4jmNzQVULggMrJGi1t5Udj6UVIlk2AcQ_4ed2nGTZU6VKzSHyIZaiyXjmy7w-xr4myiN5dsmddrElB3Na0XlMZJJYY6xXxrdkE_lwqEcjc9UH3Oq-rHJuE1tD7asixsiPEjKiJhHKZCfTex5Zo2J2tafQeMOWU4IyUavzkV7EWAiOZ1IsGneOrgUBDk5Krb8l2WF0kDlXfweXrZM5W_3f11tjH3p4Cd87fVhnS1h-ZO87wsnnDfYSOz6gaetggeAqxMpyqAKQf8QZAhkX3na3oIc-dVPDpITJa9tWDTFyC7b07aJ6aOD84jfMa7rio_ATyzs7uz0GC12s8WniEaavVGE8uk4PkZt31kA74PYT-3V2evPjnPfcDLzIpGy4Q1WYYHSqbAjodZCBLk__N0Zph8EXwviYlESUg6BTmyVOxFlxWqYhlSg22duyKnGbgXFG-TyogfNkToRzwmSFCMYEq1SOxQ47mIt8TLofExq2xOqhHi-EvsO2uu82nnZDOsYE9AgsZunnf9i9y1YIB2VdFe4XthxImrjH3hWPzaSe7bdKRffh1eUf57zaiw
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Time+trends+for+risk+of+severe+age-related+diseases+in+individuals+with+and+without+HIV+infection+in+Denmark%3A+a+nationwide+population-based+cohort+study&rft.jtitle=The+lancet+HIV&rft.au=Rasmussen%2C+Line+D&rft.au=May%2C+Margaret+T&rft.au=Kronborg%2C+Gitte&rft.au=Larsen%2C+Carsten+S&rft.date=2015-07-01&rft.eissn=2352-3018&rft.volume=2&rft.issue=7&rft.spage=e288&rft.epage=e298&rft_id=info:doi/10.1016%2FS2352-3018%2815%2900077-6&rft.externalDBID=NO_FULL_TEXT